Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model

Proceedings of the National Academy of Sciences of the United States of America
Shusei HamamichiGuy A Caldwell

Abstract

Genomic multiplication of the locus-encoding human alpha-synuclein (alpha-syn), a polypeptide with a propensity toward intracellular misfolding, results in Parkinson's disease (PD). Here we report the results from systematic screening of nearly 900 candidate genetic targets, prioritized by bioinformatic associations to existing PD genes and pathways, via RNAi knockdown. Depletion of 20 gene products reproducibly enhanced misfolding of alpha-syn over the course of aging in the nematode Caenorhabditis elegans. Subsequent functional analysis of seven positive targets revealed five previously unreported gene products that significantly protect against age- and dose-dependent alpha-syn-induced degeneration in the dopamine neurons of transgenic worms. These include two trafficking proteins, a conserved cellular scaffold-type protein that modulates G protein signaling, a protein of unknown function, and one gene reported to cause neurodegeneration in knockout mice. These data represent putative genetic susceptibility loci and potential therapeutic targets for PD, a movement disorder affecting approximately 2% of the population over 65 years of age.

References

Sep 26, 1997·The Journal of Biological Chemistry·E Ogier-DenisP Codogno
Oct 15, 1998·Proceedings of the National Academy of Sciences of the United States of America·L De VriesM G Farquhar
Nov 24, 1999·Nature Cell Biology·P RehlingS D Emr
Jan 29, 2000·Brain : a Journal of Neurology·J KamholzM E Shy
Sep 15, 2001·Science·S K KimG S Davidson
Jun 18, 2002·Science·J Paul TaylorKenneth H Fischbeck
Nov 8, 2002·Journal of Neurochemistry·Pamela J McLeanBradley T Hyman
Jan 30, 2003·Human Molecular Genetics·Guy A CaldwellKim A Caldwell
Aug 28, 2003·Médecine sciences : M/S·Christelle Gally, Jean-Louis Bessereau
Nov 1, 2003·Science·Ted M Dawson, Valina L Dawson
Nov 1, 2003·Science·A B SingletonK Gwinn-Hardy
Jan 6, 2004·Science·Siming LiMarc Vidal
Feb 27, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·He-Jin LeeSeung-Jae Lee
Apr 16, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ellen A A NollenRonald H A Plasterk
Jul 6, 2004·The Journal of Biological Chemistry·Yong ZhouJing Zhang
Apr 15, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Songsong CaoGuy A Caldwell
Sep 6, 2005·Current Biology : CB·Fiona M MenziesKyung-Tai Min
Oct 18, 2005·The Journal of Biological Chemistry·Wenbo Zhou, Curt R Freed
Dec 1, 2005·Neuroreport·Suvi AsikainenGarry Wong
Jan 31, 2006·Trends in Neurosciences·Yuri Bozzi, Emiliana Borrelli
Mar 11, 2006·Science·Weiwei Zhong, Paul W Sternberg
Sep 8, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Eugene V MosharovDavid Sulzer
Oct 21, 2006·Lancet Neurology·Jordi Pérez-Tur
Dec 8, 2006·Nature·Ed S LeinAllan R Jones
Dec 15, 2006·Nature·Luc F Van GaalChristophe E De Block
Jul 27, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·W Michael CaudleGary W Miller
Aug 30, 2007·Proceedings of the National Academy of Sciences of the United States of America·Masaaki KomatsuZhenyu Yue
Sep 1, 2007·Science·Jongpil KimAsa Abeliovich
Nov 21, 2007·WormBook : the Online Review of C. Elegans Biology·Erich M Schwarz

❮ Previous
Next ❯

Citations

Apr 26, 2013·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Sibylle E Eisbach, Tiago F Outeiro
Jul 2, 2008·Current Neurology and Neuroscience Reports·Darren J Moore, Ted M Dawson
Feb 20, 2010·Cell Stress & Chaperones·Alexander J BurdetteKim A Caldwell
Aug 12, 2009·Neurotoxicity Research·Ronald L KleinMichael A King
Mar 10, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Paige M DexterGuy A Caldwell
Mar 28, 2013·Molecular Therapy. Nucleic Acids·Arati SridharanJit Muthuswamy
Jul 15, 2009·Nature Chemical Biology·Joshua A KritzerSusan Lindquist
Jan 7, 2011·Metallomics : Integrated Biometal Science·Ebany J Martinez-FinleyMichael Aschner
Oct 15, 2009·Proceedings of the National Academy of Sciences of the United States of America·Catarina MörckMarc Pilon
Mar 23, 2011·Proceedings of the National Academy of Sciences of the United States of America·Shih-Yu ChenHwai-Jong Cheng
Sep 6, 2012·Proceedings of the National Academy of Sciences of the United States of America·Markus EnglertJimin Wang
Mar 11, 2009·Antioxidants & Redox Signaling·Saurabh Sen, Andrew B West
Sep 6, 2008·Human Molecular Genetics·Jun LiangStephan N Witt
May 31, 2012·Human Molecular Genetics·Marija UsenovicDimitri Krainc
Jun 21, 2008·Toxicological Sciences : an Official Journal of the Society of Toxicology·Maxwell C K LeungJoel N Meyer
Sep 19, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Alexander HeinickKai Lüersen
Mar 29, 2011·Cold Spring Harbor Perspectives in Biology·Rebecca C Taylor, Andrew Dillin
Mar 19, 2011·Pharmacological Reviews·Udai Bhan Pandey, Charles D Nichols
Nov 8, 2008·Molekuliarnaia biologiia·N N NinkinaV L Bukhman
Apr 8, 2009·Molecular Neurodegeneration·Philipp A Jaeger, Tony Wyss-Coray
Sep 30, 2009·Molecular Neurodegeneration·Dawn Teschendorf, Christopher D Link
Dec 3, 2008·Disease Models & Mechanisms·Guy A Caldwell, Kim A Caldwell
Mar 13, 2010·Disease Models & Mechanisms·Songsong CaoKim A Caldwell
Aug 28, 2010·Environmental Health Perspectives·Layla AitlhadjStephen Richard Stürzenbaum
Jul 25, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Shamol SahaBenjamin Wolozin
Mar 24, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Marija UsenovicDimitri Krainc
Dec 11, 2008·Journal of Visualized Experiments : JoVE·Laura A BerkowitzKim A Caldwell
May 7, 2013·Antioxidants & Redox Signaling·Fernando Muñoz-LobatoAntonio Miranda-Vizuete
Jan 6, 2010·EMBO Molecular Medicine·Tjakko J van HamEllen A A Nollen
Sep 10, 2014·Proceedings of the National Academy of Sciences of the United States of America·Shaoxiao WangStephan N Witt
Jul 30, 2014·Future Medicinal Chemistry·Mun Peak Nyon, Bibek Gooptu
Dec 7, 2013·Disease Models & Mechanisms·Michelle L ThompsonGuy A Caldwell
Jun 10, 2016·Bioengineering·Arun R ShrivatsJeffrey O Hollinger
Feb 1, 2010·Expert Opinion on Drug Discovery·Kah-Leong Lim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.